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Lung injury in mice induces mobilization of discrete subsets of epithelial progenitor cells 37 
to promote new airway and alveolar structures. However, whether similar cell types exist 38 
in human lung remains unresolved. Using flow cytometry, we identified a distinct cluster 39 
of cells expressing epithelial cell adhesion molecule (EpCAM), a cell surface marker 40 
expressed on epithelial progenitor cells, enriched in the ecto-5'-nucleotidase CD73 in 41 
unaffected postnatal human lung resected from pediatric patients with congenital lung 42 
lesions. Within the EpCAM+CD73+ population, a small subset co-express integrin β4 and 43 
HTII-280. This population remained stable with age. Spatially, EpCAM+CD73+ cells were 44 
positioned along the basal membrane of respiratory epithelium and alveolus next to 45 
CD73+ cells lacking EpCAM. Expanded EpCAM+CD73+ cells give rise to pseudostratified 46 
epithelium in 2D air-liquid interface or a clonal 3D organoid assay. Organoids generated 47 
under alveolar differentiation conditions were cystic-like and lacked robust alveolar 48 
mature cell types. Compared with unaffected postnatal lung, congenital lung lesions 49 
were marked by clusters of EpCAM+CD73+ cells in airway and cystic distal lung 50 
structures lined by simple epithelium of composed of EpCAM+SCGB1A1+ cells and 51 
hyperplastic EpCAM+proSPC+ cells. In non-small cell lung cancer (NSCLC), there was a 52 
marked increase in EpCAM+CD73+ tumor cells enriched in inhibitory immune checkpoint 53 
molecules CD47 and programmed death-ligand 1 (PD-L1), which was associated with 54 
poor survival in lung adenocarcinoma. In conclusion, EpCAM+CD73+ cells are a rare 55 
novel epithelial progenitor cell in human lung. Importantly, re-emergence of CD73 in lung 56 
adenocarcinoma enriched in negative immune checkpoint molecules may serve as a 57 
novel therapeutic target. 58 
Keywords: EpCAM; congenital lung lesions; organoids; CD73; immune checkpoint; 59 
adenocarcinoma60 




Despite being a quiescent organ at homeostasis, clinically the human lung does possess 62 
an ability for repair after various insults, although inherently low (5, 45). Nonetheless, the 63 
cellular and molecular mechanisms governing the regenerative process following lung 64 
injury have been slow in forthcoming. Moreover, the idea of a resident cell type within 65 
human lung with facultative stem cell function that is induced following injury remains 66 
controversial (25). Identifying putative cell populations in the human adult lung with 67 
facultative function and whether certain disease settings affect their numbers and 68 
function, may uncover new targets for therapeutic treatment to restore normal lung 69 
structure and function following various injuries.  70 
In human lung, epithelial cell adhesion molecule (EpCAM/CD326) is used as a 71 
biomarker enriching a population of cells endowed with stem/progenitor-like function (2). 72 
This type I single span transmembrane glycoprotein was first described as a cell surface 73 
antigen on human carcinoma cells of epithelial origin (17). Since then, a growing body of 74 
evidence has shown that EpCAM is expressed on a dynamic range of cells and is 75 
critically involved in ensuring proper endodermal/epithelial morphogenesis (46). During 76 
development, EpCAM expression wanes in terminally differentiated cells and re-77 
emerges during tissue regeneration and malignancy (34). Recently, a rare population of 78 
EpCAM-positive cells enriched in ecto-5'-nucleotidase/CD73 in human breast tissue was 79 
shown to possess enhanced cell plasticity giving rise to tissue from all three germ layers 80 
(38). Following this, high-dimensional analysis of single cells during cellular 81 
reprogramming revealed that CD73highKi67High distinguishes partially reprogrammed 82 
cells that were Oct4highKlf4highEpCAMlow (52). This transitional cell state was found to 83 
precede mesenchymal-to-epithelial transition and then pluripotency (52). CD73 is a cell 84 
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surface ectoenzyme that hydrolyzes the conversion of extracellular adenosine 85 
monophosphate to adenosine (33). In the human lung, CD73 is expressed by a wide 86 
number of cells within the mesenchymal and immune compartments (33). Within the 87 
epithelial compartment, CD73 is locally expressed on the airway mucosal and serosal 88 
surface where it is functionally active in the conversion of extracellular ATP to adenosine 89 
under normal physiological conditions (37). Hypoxia results in upregulation in 90 
CD73/adenosine, which under chronic conditions becomes maladaptive (3). 91 
Overexpression of cell surface CD73 is associated with worse clinical outcome linked 92 
with excess adenosine production in both breast (4) and ovarian cancer (47). Whether 93 
CD73 can be used to identify a discrete population of EpCAM+ cells with progenitor-like 94 
function in human lung is currently not known. Furthermore, the functional significance of 95 
this population in various settings of lung injury remain unexplored.  96 
Here, using a multiparametric approach we demonstrate that EpCAM+CD73+ cells 97 
represent a rare but stable progenitor-like population in human lung. EpCAM+CD73+ are 98 
positioned along the basal membrane of respiratory epithelium, as well as in the alveolar 99 
region in unaffected postnatal human lung. Single EpCAM+CD73+ cells give rise to 100 
pseudostratified epithelium in two-dimensional air-liquid interface or in a clonal 3D 101 
organoid assay, whereas under alveolar differentiation conditions clonal organoids were 102 
more cystic-like and lacked robust alveolar mature cell types. Analysis of congenital lung 103 
lesions revealed the presence of clusters of EpCAM+CD73+ cells in the airway, whereas 104 
cystic distal lung structures were lined by simple epithelium consisting of 105 
EpCAM+SCGB1A1+ cells and hyperplastic EpCAM+proSPC+ cells. An upregulation of 106 
EpCAM+CD73+ tumor cells enriched in inhibitory immune checkpoint molecules CD47 107 
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and programmed death-ligand 1 (PD-L1), which was associated with poor survival, was 108 
revealed in lung adenocarcinoma.  109 
110 
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Materials and Methods 111 
Collection of lung tissue 112 
Collection and processing of human lung tissue was performed as previously described 113 
(49). Briefly, resected tissues were collected from pediatric patients undergoing elective 114 
surgery for congenital lung lesions and other lung abnormalities at Children’s University 115 
Hospital of Zurich (see Table S1), as well as adult patients undergoing resection for non-116 
small cell lung cancer (NSCLC) or metastasis to the lung (see Table S2 and S3) at Bern 117 
University Hospital, Department of Thoracic Surgery. The use of surgically resected 118 
material for research purposes was provided by all patients included in this study, which 119 
was approved by the Ethics Commission of the Canton of Bern (KEK-BE:042/2015). All 120 
supplemental material is available at https://doi.org/10.6084/m9.figshare.12488867. 121 
 122 
Flow cytometric analysis, prospective cell isolation and generation of primary 123 
cultures 124 
Generation of single cell suspensions for flow cytometric analysis and prospective cell 125 
isolation were performed as previously described (49). Briefly, single cells from digested 126 
lung tissue were stained with fluorescently conjugated human monoclonal antibodies 127 
targeting: CD45, CD14, CD31, CD73, CD90, EpCAM (see Table S7). Following sorting, 128 
EpCAM+CD73+ cells (see Figure 1C and Supplemental Fig. S1 for full gating strategy) 129 
were plated on dishes pre-coated with a solution consisting of 0.2% gelatin, 0.3 mg/ml of 130 
human collagen I (Sigma) and 0.03 mg/ml of human collagen IV (Sigma). Cells were 131 
grown in cell expansion media (see Table S8) and maintained in a humidified 37°C low 132 
oxygen (3% O2) incubator in 5% CO2. An additional FACS analysis was performed on a 133 
second cohort of postnatal (n = 6; PL017-PL022) and adult lungs (n = 6; patient 10-15, 134 
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see Table S1) using the same antibody backbone as described above with addition of 135 
the following antibodies: CD146, NOTCH3 and integrin β4 (CD104) (see Table S7). To 136 
further immunophenotype the epithelial progenitor cell population, we stained a third 137 
cohort of lung tissue (postnatal, n = 6; PL029-PL035 and adult lungs, n = 7; patient, see 138 
Table S1 and S2) using our original antibody backbone with addition of the following 139 
antibodies: HTII-280, CD24 and PDPN (see Table S7). 140 
 141 
Immunophenotype of cell subsets using flow cytometry 142 
Following isolation and expansion of EpCAM+CD73+ cells (see Figure 2A and Table 143 
S10), cells were harvested and re-suspended in FACS staining buffer. Following Fc 144 
block, cells were incubated with the following fluorescently conjugated human 145 
monoclonal antibodies: integrin β4, EpCAM, CD47 (see Table S7). Cells were incubated 146 
on ice in the dark for 30 minutes. To exclude dead cells and debris, 7-AAD was added. 147 
Cell acquisition was performed using a BD FACS LSRII. For analysis, a minimum of 148 




Preparation of lung tissue for immunostaining was performed as previously described 153 
(49). Briefly, 5 µm sections of were stained with hematoxylin & eosin using standard 154 
protocols. For immunofluorescence, 5 µm sections were stained with a panel of human 155 
monoclonal antibodies: EpCAM, CD73, CD90, SOX2, KRT5, TRP63, integrin β4, 156 
SCGB1A1 and proSPC on different tissue samples (see Table S1 and Table S8-9). 157 
Following immunostaining, high resolution images were acquired with a Zeiss LSM 710 158 
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Confocal Microscope. Collected images were imported into Imaris software Ver 7.6 159 
(Bitplane, CH). Quantification of cell phenotype was performed by sampling five random 160 
fields (20X) taken from disease regions and the matched normal region in three patients. 161 
Firstly, 100-200 airway epithelial cells were counted based on DAPI/EpCAM staining. 162 
Cells that were SCGB1A1+ were also counted. From the same patients, the percentage 163 
of EpCAM+proSPC+ cells relative to EpCAM+ cells were assessed from five random 164 
fields in each slide (20X). 165 
 166 
2D air-liquid interface 167 
Passage 3 EpCAM+CD73+ epithelial cells were counted and single cells were seeded 168 
onto transwell inserts (0.4 µm Transwell insert, Corning) in expansion media on both the 169 
apical and basal side of the insert. After two days, media was removed from both the 170 
apical and basal surface and cells were grown at air-liquid interface (ALI) in airway 171 
differentiation media (PneumoCult™-ALI medium, StemCell Technologies). Regular 172 
media changes from the basal surface were made every three days. After 21 days, cells 173 
were fixed with 70% ethanol (Sigma). For immunofluorescence (IF), inserts were 174 
incubated with cooled solution of 95% ethanol / 5% glacial acetic acid for 10 minutes for 175 
permeabilization and washed 3X in TBS solution. Afterwards, inserts were blocked with 176 
3% goat serum (blocking solution) for 1 hour at room temperature. Inserts were 177 
incubated overnight at 4°C with primary antibodies to detect mucous secreting cells, 178 
goblet, club and basal stem cells (see Table S6). Secondary antibodies (see Table S9) 179 
were diluted in washing solution and added to the inserts, which were incubated for 2 180 
hours at room temperature. Nuclei were counterstained with DAPI. High resolution Z-181 
axis images were acquired with a Zeiss LSM 710 Confocal Microscope. Images were 182 
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collected and imported into Imaris software Ver 7.6 (Bitplane, CH) to recreate three-183 
dimensional (3D) volume reconstruction of the data set to visualize cell surface areas 184 
and volume performed using the Surpass tool. To examine the role of the NOTCH 185 
signaling pathway, separate wells were treated with delta-like ligand 4 (DLL4, 10 ng/ml, 186 
Peprotech) or γ-secretase inhibitor DAPT (20 µM, Sigma) or vehicle (DMSO, Sigma) at 187 
every media change and samples were processed for IF, as described above. From 188 
images, 5 random fields were counted in three technical replicates at 40X magnification. 189 
The total cell amounts based on the E-cadherin staining, then counted SCGB1A1+, 190 
MUC5AC+ and β-tubulin+ cells respectively. 191 
 192 
3D organoid culture 193 
To generate airway organoids, single EpCAM+CD73+ cells from postnatal or adult lung 194 
were mixed with autologous CD90+ stromal cells at a 1:1 ratio and resuspended in 50% 195 
solution of growth factor reduced matrigel (Corning) and seeded into inserts (0.4 µm 196 
Transwell insert, Corning). After solidification of matrigel:cell solution, airway 197 
differentiation media (PneumoCultTM) was added to the basal chamber. Fresh media 198 
changes were made every 2 days for 21 days. To generate alveolar organoids, a 40% 199 
solution of growth factor reduced matrigel (Corning) was seeded into 0.4 µm Transwell 200 
inserts (Corning) and allowed to solidify forming a base. Afterwards, a 5% matrigel 201 
solution containing EpCAM+CD73+ cells with autologous CD90+ stromal cells at a 1:1 202 
ratio was seeded onto the top of matrigel base. 800 µl of expansion media was added to 203 
the basal chamber exposing cells to ALI. Transwell inserts were maintained in a 204 
humidified 37°C oxygen (21%) incubator in 5% CO2 for expansion/differentiation. After 205 
24 hours, media was removed from the apical surface and not replaced to mimic ALI, 206 
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whereas a fresh media change to the lower chamber was made using distal airway 207 
media (see Table S12) and media was changed every two days. After 21 days, inserts 208 
were fixed with 70% ethanol and processed for IF or removed from matrigel using 209 
dispase (Corning). High resolution Z-axis images were acquired with a Zeiss LSM 710 210 
Confocal Microscope. Images were collected as lsm files and imported into Imaris 211 
software (Ver7.6) to recreate 3D volume reconstruction of the data set to visualize cell 212 
surface areas, organoid volume and cell-cell communication using the Surpass tool.  213 
 214 
Transmission electron microscopy 215 
Airway organoids were recovered from the matrigel using dispase (Corning) and 216 
submerged with fixative consisting of 2.5% glutaraldehyde (Agar Scientific, Stansted, 217 
Essex, UK) in 0.15M HEPES (Fluka, Buchs, Switzerland) with an osmolarity of 709 218 
mOsm and adjusted to a pH of 7.34. The organoids remained in the fixative at 4°C for at 219 
least 24h, before being further processed. All samples were then washed with 0.15 M 220 
HEPES three times for 5 min, post fixed with 1% OsO4 (SPI Supplies, West Chester, 221 
USA) in 0.1 M Na-cacodylate-buffer (Merck, Darmstadt, Germany) at 4°C for 1 h, 222 
washed with 0.05 M maleat-NaOH buffer (Merck, Darmstadt, Germany) three times for 5 223 
min, and then block stained in 0.5% uranyl acetate (Fluka, Buchs, Switzerland) in 0.05 M 224 
maleat-NaOH buffer at 4°C for 1 h. Thereafter, cells were washed in 0.05 M maleat-225 
NaOH buffer three times for 5 min and dehydrated in 70, 80 and 96% ethanol 226 
(Alcosuisse, Switzerland) for 15 min each at room temperature. Subsequently, cells 227 
were immersed in 100% ethanol (Merck, Darmstadt, Germany) three times for 10 min, in 228 
acetone (Merck, Darmstadt, Germany) two times for 10 min, and finally in acetone-epon 229 
(1:1) overnight at room temperature. The next day, cells were embedded in epon (Fluka, 230 
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Buchs, Switzerland) and left to harden at 60°C for 5 days. Sections were produced with 231 
an ultramicrotome UC6 (Leica Microsystems, Vienna, Austria), first semi-thin sections (1 232 
um) for light microscopy which were stained with a solution of 0.5% toluidine blue O 233 
(Merck, Darmstadt, Germany) and then ultrathin sections (70-80 nm) for electron 234 
microscopy. The sections, mounted on single slot copper grids, were stained with uranyl 235 
acetate and lead citrate with an ultrostainer (Leica Microsystems, Vienna, Austria). 236 
Sections were then examined with a transmission electron microscope (CM12, Philips, 237 
Eindhoven) equipped with a digital camera (Morada, Soft Imaging System, Münster, 238 
Germany) and image analysis software (iTEM). 239 
 240 
RNA extraction and real time quantitative PCR 241 
Total RNA was extracted from cells or organoids using RNeasy Mini Kit (Qiagen) to 242 
analyze gene expression using real time quantitative PCR (RT-qPCR). RT-qPCR was 243 
performed in triplicates with target-specific primers using TaqMan Gene Expression 244 
Assay (Applied Biosystems) on AB7500 FAST real-time PCR system (Applied 245 
Biosystems). Expression levels were normalized to 3 internal controls tested for 246 
expression stability across samples in each experiment using Expression Suite Software 247 
(Life Technologies). Relative expression was calculated by 2-ΔΔCT method. (see Table S6 248 
for primer list).  249 
 250 
PD-L1 and CD47 immunohistochemistry 251 
Serial sections from formalin-fixed and paraffin-embedded human lung adenocarcinoma 252 
(LUAD, n = 27) and lung squamous cell carcinoma (LUSC, n = 31) cases were stained 253 
for programmed death ligand-1 (PD-L1) and CD47. Immunohistochemical staining was 254 
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performed using an automated immunostainer (Bond III, Leica Biosystems, Muttenz, 255 
Switzerland) using the following antibodies: anti-human PD-L1 (clone E1L3N, Cell 256 
Signaling Technology, Damvers, MA, USA) at a dilution of 1:400 and anti-human CD47 257 
(clone B6H12, Santa Cruz, San Diego, USA) at a dilution of 1:20. Sections were 258 
incubated with primary antibodies at room temperature for 15 minutes, followed by 259 
incubation with the secondary antibody using the Bond Polymer Refine Kit with 3-3’-260 
Diaminobenzidine-DAB as chromogen (Leica Biosystems), counterstained with 261 
hematoxylin and mounted in Aquatex (Merck, Darmstadt, Germany). Membranous CD47 262 
expression was scored 0-3 by a trained pathologist (SB). Tumoral PD-L1 expression 263 
was scored by a trained pathologist (SB) according to current guidelines as the 264 
percentage of cells with membranous staining of any intensity (tumor proportion score) 265 
and grouped as follows: <1%; between 1 to <50%; and ≥50%, as previously described 266 
(22) (see Table S5 and S6). For double immunohistochemistry of postnatal lung tissue, 267 
rabbit PD-L1 antibody (clone E1L3N) was diluted 1:400, incubated for 30 min. Samples 268 
were incubated with Horseradish Peroxidase (HRP)-polymer for 15 min and visualized 269 
using DAB as brown chromogen (Bond polymer refine detection, Leica Biosystems) for 270 
10 min. Following this, slides were incubated with mouse ERG antibody (Agilent, 271 
M73149) diluted at 1:50 for 30 min. Following this, slides were incubated with secondary 272 
antibody Alkaline phosphatase (AP)-polymer for 15 min, and visualized using fast red as 273 
red chromogen (Red polymer refine Detection, Leica Biosystems). Samples were 274 
counterstained with haematoxylin and mounted with Aquatex (Merck). All slides were 275 
scanned and photographed using Pannoramic 250 (3DHistech). 276 
 277 
Statistical analysis 278 
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Data are expressed as mean ± SD. Comparisons between two groups were carried out 279 
using the parametric student’s two-tailed paired or unpaired t-test for normally distributed 280 
data. If data were not distributed normally, a nonparametric Wilcoxon signed-rank test 281 
was used between the two groups. All tests were two-tailed. Analysis of more than two 282 
groups was performed with ANOVA followed by Newman-Keuls post hoc test. The 283 
numbers of samples (biological replicates) per group (n), or the numbers of experiments 284 
(technical replicates) are specified in the figure legends. Data was analyzed using 285 
GraphPad Prism 8 software. Statistical significance is accepted at P < 0.05.  286 




CD73+ labels a rare population of EpCAM+ progenitor cells in both airway and 288 
alveolar region of unaffected human lung 289 
As shown in the schematic panel in Figure 1A, we applied a multiparametric approach to 290 
identify and characterize resident lung epithelial progenitor cells in a cohort of pediatric 291 
patients (herein called postnatal) undergoing elective surgery for congenital lung lesions 292 
and other airway abnormalities (see Table S1) and adult patients diagnosed with 293 
NSCLC undergoing elective surgery for curative intent (see Table S3). We previously 294 
reported the presence of an EpCAMneg (gate R4) mesenchymal cluster further 295 
fractionated on the basis of CD73/CD90 in unaffected postnatal lung using 296 
polychromatic flow cytometry (49). Here, unlike cells in the EpCAMneg, we show that the 297 
EpCAMpos fraction (gate R5, Figure 1B and Fig. S1A) contains a cluster of cells enriched 298 
for 5`ecto-nucleotidase CD73 (gate R6, 11.8±9.9%, Figure 1C and Supplemental Fig. 299 
S1A, D). In contrast, CD73+ cells co-expressing membrane glycoprotein CD90 (THY-1) 300 
or single CD90+ cells were rare (CD73+CD90+, 0.8±0.8% and CD73-CD90+, 3.9±2.8%, 301 
Figure 1D and Supplemental Fig. S1B-E). Surprisingly, there was no difference in the 302 
percent of EpCAM+CD73+ cells between postnatal and adult lung tissue (Figure 1E and 303 
Supplemental Fig. S1F).  304 
Next, we wanted to localize EpCAM+CD73+ cells in postnatal lung. Apart from 305 
standard histological analysis based on H&E performed on unaffected lung tissue 306 
(Figure 1F-H), we immunostained separate sections with EpCAM and CD73. Confocal 307 
analysis revealed dual EpCAM/CD73 labelled cells occupying a basal position in the 308 
airway (Figure 1G, white arrow). In the alveolar region, cuboidal shaped cells co-staining 309 
for EpCAM and CD73 (white arrows) were found next to flat squamous-like CD73+ cells 310 
Downloaded from journals.physiology.org/journal/ajplung at Univ Bern Hosp (161.062.252.040) on August 19, 2020.
13 
 
(white arrowhead) lacking EpCAM (Figure 1I). Further, EpCAM+ cells in the airway co-311 
stain with the transcription factor SRY-Box 2 (SOX2), whereas in the alveolar region 312 
were shown to express the ATII marker prosurfactant protein C (proSPC) (Supplemental 313 
Fig. S1G-H). 314 
 315 
Prospectively isolated EpCAM+CD73+ cells resemble basal-like stem cells in 316 
culture  317 
Next, using FACS we prospectively isolated EpCAM+CD73+ cells from unaffected 318 
postnatal lung tissue and expanded cells in feeder-free plates using a chemically-319 
defined growth media (Figure 2A). At the mRNA level, EpCAM+CD73+ cells were 320 
enriched for SOX2 and Keratin 5 (KRT5), as well as the basal stem cell transcription 321 
factor p63 (TRP63) (Figure 2B). Expression of genes defining mature cell types were not 322 
observed or low. Interestingly, there was a 2-fold increase in hypoxia inducible factor 323 
HIF1α expression in EpCAM+CD73+ cells (Figure 2B). Immunostaining sorted cells after 324 
reaching confluence in culture revealed that the majority of expanded EpCAM+CD73+ 325 
cells express the laminin receptor integrin β4, which supports cell adhesion between 326 
basal epithelial cells and basement membrane (28). This was confirmed using flow 327 
cytometry (Supplemental Fig. S2A). Variable expression for SOX2 and KRT5 were 328 
observed, as well as lack of expression of proSPC and the club cell marker SCGB1A1 329 
(Figure 2C-E). FACS analysis on independent postnatal specimens revealed that a 330 
small fraction of postnatal EpCAM+CD73+ cells co-express integrin β4 ex vivo 331 
(Supplemental Fig. S2B), which did not differ in adult lung (postnatal, 10.7±11% versus 332 
adult, 7.1±5.6%, Supplemental Fig. S2C). Immunostaining of postnatal human lung 333 
revealed integrin β4+ cells located along the basal membrane of the conducting airway 334 
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co-expressing KRT5 (Supplemental Fig. S2D), whereas integrin β4+ cells co-expressing 335 
proSPC in the alveolar region were rare (Supplemental Fig. S2E-F). To further 336 
immunophenotype the EpCAM+CD73+ population in vivo, we stained an additional six 337 
independent postnatal and seven adult tissue samples and show that a small subset 338 
within the EpCAM+CD73+ population co-express the ATII marker HTII-280 (15) in both 339 
postnatal (3.6±2.5%) and adult human lung (3.4±4.2%) (Figure 2F-G and Supplemental 340 
Fig. S2G, H). Moreover, sequential gating show variable expression of CD24 and PDPN 341 
within EpCAM+CD73+HTII-280- and EpCAM+CD73+HTII-280+ subsets (Supplemental 342 
Fig. S2I-K). Taken together, EpCAM+CD73+ cells represent a rare but heterogeneous 343 
population in human lung. Our submersion culture conditions appear to favour the 344 
expansion of cells toward a SOX2+ basal stem-cell like state (Figure 2H), consistent with 345 
primary sorted Sox2+EpCAM+β4+Krt5- progenitor cells derived from murine lungs (50). 346 
 347 
Generating airway epithelium from single EpCAM+CD73+ cells 348 
Based on the location of EpCAM+CD73+ cells in the airway of postnatal lung and gene 349 
expression pattern following expansion in culture, we next investigated the airway 350 
differentiation capability of EpCAM+CD73+ cells from postnatal and adult lung tissue. 351 
Standard H&E of a lung section from the unaffected postnatal lung show normal lung 352 
structure including a bronchiole and surrounding alveolus (Figure 3A and Supplemental 353 
Fig. S3A). Using confocal microscopy, a single bronchiole is highlighted showing the 354 
airway epithelium stains for EpCAM/SOX2, whereas KRT5+ cells (green) can be seen 355 
occupying the basal layer only (Figure 3B and Supplemental Fig. S3B). In separate 356 
sections, epithelial cells lining the basal membrane of the airway express the basal stem 357 
cell marker TRP63 (white arrowhead), some of which co-express KRT5 (white arrow, 358 
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Figure 3C and Supplemental Fig. S3C). We seeded single FACS-sorted EpCAM+CD73+ 359 
cells at air-liquid-interface (ALI) to induce airway differentiation (Figure 3D). After 21 360 
days, postnatal EpCAM+CD73+ cells give rise to pseudostratified multiciliated-secretory 361 
epithelium (left panels, Figure 3D and Supplemental video S1). Persistent 362 
pharmacological activation of NOTCH signaling using the precanonical NOTCH ligand 363 
DLL4 during airway differentiation reduced both goblet (MUC5AC, white) and secretory 364 
club cell (SCGB1A1, purple) formation whereas cilia (β-tubulin, yellow) formation was 365 
intact (middle panels, Figure 3D and Supplemental Fig. S3D). Immunostaining with E-366 
cadherin (green) and 3D volume rendering through the zy plane show an intact 367 
pseudostratified barrier and TRP63+ (red) cells along the basal membrane (Figure 3D-368 
E). Pharmacological inhibition of NOTCH signaling using gamma secretase inhibitor 369 
DAPT also decreased the formation of both goblet cells and secretory club cells leaving 370 
cilia formation intact (far right panels, Figure 3D and Supplemental Fig. S3D). However, 371 
formation of a pseudostratified barrier was disrupted (Figure 3E). In comparison with 372 
adult-derived EpCAM+CD73+ cells, we noted several differences (Figure 3F). First, adult-373 
derived EpCAM+CD73+ cells required the presence of autologous CD90+ stromal cells to 374 
ensure proper airway differentiation (left panels, Figure 3F and Supplemental video S2). 375 
Second, the formation of a mucociliary epithelium was intact despite persistent NOTCH 376 
signaling (middle panels Figure 3F and Supplemental Fig. S3E). Third, inhibition of 377 
NOTCH signaling reduced cilia formation (Figure 3F and Supplemental Fig. S3E), yet 378 
the disruption in the formation of pseudostratified barrier was similar with postnatal lung 379 
EpCAM+CD73+ cells (Figure 3G).  380 
 381 
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EpCAM+CD73+ cells generate three-dimensional organoid structures with airway 382 
and alveolar-like features 383 
The self-organizing feature possessed by adult stem cells is indispensable for the 384 
formation of organoids, which are three dimensional (3D) structures recapitulating 385 
important characteristics of the organ they represent (32). Thus, we next asked whether 386 
EpCAM+CD73+ cells could give rise to organoids that recapitulate human airway found 387 
in vivo. We seeded single EpCAM+CD73+ cells together with single autologous CD90+ 388 
mesenchymal cells from the postnatal or adult lung in 3D matrigel, exposing the apical 389 
surface to air while culturing in human airway differentiation media in the basal chamber 390 
(Figure 4A). After 21 days, transmission electron microscopy demonstrated that 391 
organoid structures were morphologically similar to in vivo pseudostratified mucociliary 392 
epithelium (Figure 4B). Ciliated cells and secretory cells can be found facing inside the 393 
lumen of the organoid structure and small basal-like cells in the basal layer. At the 394 
mRNA level, airway organoid structures upregulated genes found to be enriched in 395 
airway (Figure 4C). Organoids with beating cilia can be detected after removal from 396 
matrigel (Supplemental video 3 and 4).  397 
 Next, we explored whether EpCAM+CD73+ cells could generate organoids with 398 
alveolar-like features. Single postnatal EpCAM+CD73+ cells with autologous CD90+ 399 
stromal cells were suspended in a solution of matrigel (5%), which was  overlaid on a 400 
base of matrigel (40%) and grown in a modified alveolar induction media placed in the 401 
basal chamber biased towards alveolar differentiation (Figure 4D). After 21 days, 402 
confocal imaging of an organoid shows the presence of rare ATII-like cells positive for 403 
proSPC at the apical surface of the lumen (white arrow, Figure 4E and Supplemental 404 
Fig. S4A-B). In separate organoids, rare cells positive for the ATI marker HOPX can be 405 
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observed, which were distinct from KRT5+ stained cells (Figure 4F and Supplemental 406 
Fig. S4C). Similar results were observed for alveolar organoids derived from adult 407 
EpCAM+CD73+ cells (Supplementary Fig. S4D-E). FACS analysis revealed the presence 408 
of EpCAM+CD73+HTII-280- and EpCAM+CD73+HTII-280+ cells using FACS at levels 409 
similar to those found in vivo (Figure 4G, H). However, the level of single positive HTII-410 
280 epithelial cells was diminished (organoids, 13.42±4.84% and postnatal lung, 411 
55.3±26.7%). Co-expression of CD24 and PDPN were upregulated in alveolar organoids 412 
(Figure 4I, J). Moreover, a greater percent of EpCAM+CD73+ cells co-expressed β4+ 413 
cells compared with in vivo native postnatal lung (organoids, 40.6±31% and postnatal 414 
lung, 11.55±15%) (Supplemental Fig. S4F-G). 415 
 416 
Expansion of EpCAM+CD73+ cells together with mature epithelial cell lineages in 417 
congenital lung lesions and other airway abnormalities  418 
To determine whether the EpCAM+CD73+ cell subset or other cell lineages are induced 419 
after lung injury, we performed immunofluorescence analysis of matched lung tissue 420 
obtained from patients diagnosed with congenital lung lesions and other airway 421 
abnormalities (Table S1). Standard H&E staining show structural airway malformations 422 
and cystic lesions from representative patients (Figure 5A-D and Supplemental Fig. S5). 423 
In highlighted regions of H&E sections (Figure 5E, G), clusters of EpCAM+CD73+ cells in 424 
the airway of a patient with CPAM (Figure 5F) or chronic bronchiolitis (Figure 5H) can be 425 
observed with confocal imaging. In a separate patient with congenital intrapulmonary 426 
sequestration, H&E shows the dysplastic alveolar epithelium (Figure 5I) and 427 
corresponding confocal image shows the extent of EpCAM/CD73 localization (Figure 428 
5J). There was no evidence of clusters of TRP63+KRT5+ cells migrating from the 429 
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proximal airway or ectopic TRP63+KRT5+ or KRT5+ cells in the distal lung between 430 
cystic lesions or in dysplastic alveolar regions in CPAM tissue (Figure S6D-F). 431 
Moreover, in these same patients, EpCAM+SOX2+ or EpCAM+SOX2+KRT5+ cells were 432 
observed in the basal layer of cysts but not in the thickened interstitium (Supplemental 433 
Fig. S6G-I).  434 
Confocal imaging analysis demonstrated that cystic lesions and areas of 435 
dysplastic alveolar epithelium were lined with hyperplastic EpCAM+proSPC+ cells (yellow 436 
arrow), either as single cells or as clusters in patients with congenital lung lesions 437 
(Figure 6A-F). In other regions, bronchiolar lined cysts of cuboidal and columnar 438 
epithelium stained positive for EpCAM+SCGB1A1+ (yellow arrowhead), as well as lining 439 
the airways in the damaged region of the lung (Figure 6A-F). We noted a significant 440 
increase in both EpCAM+proSPC+ and EpCAM+SCGB1A1+ cell subtypes (Figure 6G). In 441 
cystic lung lesions we did not observe dual positive proSPC-SCGB1A1 cells indicative of 442 
putative bronchioalveolar stem/progenitor cell with regenerative potential, as described 443 
in various mouse models of lung injury (29, 40).  444 
 445 
EpCAM+CD73+ cells re-emerge in lung adenocarcinoma and upregulate immune 446 
checkpoint molecules PD-L1 and CD47 447 
CD73 has emerged as a novel therapeutic target in solid tumors due its role in the 448 
enzymatic generation of the immunosuppressive molecule adenosine (1). We 449 
investigated whether there is re-emergence of CD73 expression on tumor epithelial cells 450 
marked by EpCAM in NSCLC and whether this cell cluster expresses additional 451 
inhibitory immune checkpoint molecules involved in immune resistance. To accomplish 452 
this, we profiled the composition of tumor epithelium (EpCAM+) and matched uninvolved 453 
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lung tissue using polychromatic flow cytometry in a cohort of 122 surgically resected 454 
stage I to IV NSCLC tissues. Clinical and pathologic characteristics for all patients are 455 
found in Table S3. In representative patients, H&E staining shows tumor islands 456 
surrounded by stroma (Figure 7A, C and Supplemental Fig. S7). Confocal imaging 457 
demonstrated that EpCAM+ tumor islands co-stain for CD73 (Figure 7B). A serial section 458 
confirmed that these cells also were TRP63 positive (Figure 7D and Supplemental Fig. 459 
S7B-C, E). Flow cytometric analysis demonstrated an enrichment in EpCAM+ tumor cells 460 
co-expressing CD73 in lung adenocarcinoma (LUAD) (Figure 7E). In the lung squamous 461 
cell carcinoma (LUSC) cohort, there was an enrichment in EpCAM+CD73+ cells in tumor 462 
in subsets of patients; however, overall this was not significant (Figure 7F). The 463 
inhibitory immune checkpoint molecule PD-L1 was upregulated in the EpCAM+CD73+ 464 
TC fraction in both LUAD and LUSC (Figure 7G, H). Interestingly, membrane expression 465 
of CD47, a “don’t eat me signal” and inhibitory checkpoint molecule of the innate 466 
immune system, was found to be overexpressed in the EpCAM+CD73+ TC fraction only 467 
in LUAD (Figure 7G, H). Comparison of LUAD with LUSC revealed a difference only in 468 
EpCAM+CD73+ cells (Supplemental Fig. S7F-I). To determine the level of colocalization 469 
of tumoral PD-L1 and CD47, we performed immunohistochemistry on serial sections of 470 
58 NSCLC cases (LUAD, n = 27; LUSC, n = 31). Representative micrographs of serial 471 
sections capture the heterogeneity in tumoral PD-L1 and CD47 co-expression (Figure 472 
7I), which was depicted in an expanded number of cases (Supplemental Fig. S7J-K) and 473 
quantified in table format (Supplemental Table S5 and S6). Surprisingly, we did not 474 
detect PD-L1 expression within the epithelium of congenital lung lesions we examined 475 
despite immune infiltration being present in some case (Supplemental Fig. S8). 476 
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Based on the compositional features identified in LUAD and LUSC the following 6 477 
markers CD73 (NT5E), EpCAM (EPCAM), CD90 (THY1), PD-L1 (CD274), CD47 and 478 
CD127 (IL-7R) were used to determine their clinical relevance in predicting patient 479 
survival using mRNA expression data from The Cancer Gene Atlas (TCGA) NSCLC 480 
cohort. We were able to build a compound Cox proportional-hazards model to find the 481 
best combination of the 6-gene signature associated with survival. In LUAD, we found a 482 
compound model whereby increased expression of CD73 at the mRNA level was 483 
associated with shorter patient survival, whereas this was not the case for LUSC (Figure 484 
7J). Taken together, these data highlight the importance of CD73 as a potential novel 485 
drug target in adenocarcinoma histology. 486 
487 




Here, we show that CD73 enriches for a rare EpCAM+ cell subset isolated from healthy 489 
postnatal and adult human lung tissue that can give rise to pseudostratified mucociliary 490 
epithelium, and to a limited extent, mature alveolar cell types. Spatially, EpCAM/CD73 491 
double positive cells were found in the respiratory epithelium and alveolar region. 492 
Importantly, this rare population remains stable during lung maturation. In congenital 493 
cystic lung lesions and other airway abnormalities foci of EpCAM+CD73+ cells line the 494 
airway epithelium. Interestingly, in LUAD EpCAM+CD73+ cells re-emerge and co-495 
express CD47 and PD-L1, proteins that negatively regulate host innate and adaptive 496 
immune responses, respectively, and are known to contribute to tumor immune escape.  497 
A significant challenge in the field is the use of surface-marker based phenotyping 498 
to identify cell types in human lung endowed with stem cell function under stable 499 
conditions and during perturbations. Using EpCAM as a surrogate marker of normal lung 500 
stem cells, Hogan and colleagues were the first to demonstrate that EpCAM+ cells co-501 
expressing the ATII maker HTII-280 (15) function as bona fide ATII stem cells when 502 
cocultured with niche cells (2). Following this, numerous studies have since confirmed 503 
the use of EpCAM to isolate lung progenitors from human iPSCs to generate 3D lung 504 
organoids with both airway and alveolar features (8, 12, 16), and to isolate ATII cells for 505 
downstream characterization within adult human lung (7, 9) Using a flow cytometric 506 
approach, we demonstrate that a small subset of postnatal lung EpCAM+CD73+ cells co-507 
express this HTII-280, which does not change with age. The alveolar differentiation 508 
potential of EpCAM+CD73+ cells was rare, despite immunostaining data showing 509 
anatomically distinct cuboidal shaped EpCAM+CD73+ cells in the alveolar region. In 510 
sharp contrast, 2D or 3D airway differentiation potential of culture expanded 511 
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EpCAM+CD73+ cells was robust. A limitation may be the inability to expand bona fide 512 
human alveolar progenitor cells, which are SFPC+ (18) and the intervening period of 513 
submersion culture in vitro. In murines, submersion culture induces hypoxia-driven 514 
hyperactive NOTCH signaling that favour the expansion of cells toward a Sox2+ basal 515 
stem-cell like state and impairs their alveolar differentiation potential (50). We observed 516 
that 11% of EpCAM+CD73+ cells in vivo express integrin β4, yet after submersion culture 517 
integrin β4 was universally expressed. Therefore, 2D in vitro culture may select for 518 
airway-derived EpCAM+CD73+ cells that are committed towards a basal cell state. 519 
Interestingly, a fraction of EpCAM+CD73+HTII-280+ cells were recovered from alveolar 520 
organoids similar to what was observed in native lung. Despite this, we noted that the 521 
percent of EpCAM+HTII-280+ cells was considerably lower compared with native lung. 522 
Alveolar organoids were generated with autologous CD90+ mesenchymal cells in a 523 
media that has been shown to favour alveospheres (2). Whether CD90+ mesenchymal 524 
cells this impairs alveolar differentiation due to excessive TGF-β1 activation originating 525 
from the mesenchyme compartment requires further investigation (35). 526 
CPAM includes a wide range of developmental lung malformations arising in 527 
utero marked by cystic and/or adenomatous pulmonary areas, which was consistent with 528 
previous reports (14, 26, 43, 44). In between cystic airspaces, the distal lung is marked 529 
by thickened interstitial spaces lined by simple epithelium with expanding EpCAM+ cells 530 
expressing the club cell marker secretoglobin SCGB1A1, whereas dysplastic alveolar 531 
epithelium is marked by cuboidal EpCAM+ cells coexpressing proSPC. We did not 532 
observe SCGB1A1+proSPC+ putative bronchioalveolar stem cells nor regenerating pods 533 
of TRP63+KRT5+ cells, as has been described in murine models of lung injury and 534 
cancer (23, 24, 30, 39, 40, 48). Although incompletely understood, CPAM is thought to 535 
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arise due to altered branching morphogenesis during fetal lung development. Recent 536 
evidence based on transcriptome-wide analysis of congenital lung lesions revealed 537 
dysregulated expression of genes related to RAS and PI3K-AKT-mTOR pathway 538 
together with a cell-autonomous defect in growth and airway differentiation of isolated 539 
EpCAM+ cells (44). (49). EpCAM is not restricted to the respiratory tract, however and 540 
whether these cells were enriched in CD73 and the mechanism driving their expansion 541 
was not described. In human fetal lung explants, coordination between highly 542 
proliferative dual positive SOX2-SOX9 progenitor cells located at distal branching tips 543 
with smooth muscle cells (SMC) in time and space is implicated in proper branching 544 
morphogenesis (10). Importantly, we show that EpCAM+CD73+ cells co-express both 545 
SOX2 and SOX9 at the mRNA level. We previously demonstrated in CPAM that thick 546 
interstitial spaces were filled with mesenchymal cells (49). It is presently unclear whether 547 
the mesenchyme plays a causative role in congenital lung lesions and requires further 548 
investigation.  549 
The natural evolution of CPAM also posses an increased risk for malignancy, 550 
although the true incidence is still not known (26). Lung tumors associated with CPAM in 551 
children range from rhabdomyosarcoma (RMS), pleuro-pulmonary blastoma (PPB), 552 
whereas in the adult, bronchioalveolar carcinoma (BAC) and adenocarcinoma are more 553 
common (6). Goblet cell proliferation, which has been described in CPAM may represent 554 
a precursor lesion to lung adenocarcinoma in children (13). Along these lines, various 555 
changes in several notable genes including FGF10, FGFR2b, SOX2 and mutations in 556 
KRAS at codon 12 was associated with adenocarcinoma. Recently, whole exome 557 
sequencing a cohort of eighteen CPAM patients revealed mutations linked to lung 558 
development and cancer development (19). As eluded to above, one of the main 559 
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difficulties has been in inability to identify the cell of origin of lung cancer in humans. 560 
Moving forward it will be necessary to perform single-cell transcriptome analysis and 561 
differentiation trajectory inference to uncover the fate of EpCAM+CD73+ cells when 562 
moving from normal to aged and CPAM lung (51).  563 
Regulatory networks important during development can re-emerge after tissue 564 
injury and malignant transformation (17). One such regulatory molecule is CD73. Our 565 
data in LUAD along with findings from breast (4) and ovarian cancer (47) suggest that 566 
CD73 represents a critical target in solid tumors. Functionally, this cell type ectoenzyme 567 
CD73 involved in generation of the signaling molecule adenosine via dephosphorylation 568 
of adenosine monophosphate. Production of extracellular adenosine functions as an 569 
immune suppressor initiating a cascade of events that counterbalance pro-inflammation. 570 
Under chronic inflammatory conditions, adenosine signalling can be maladaptive 571 
contributing to tumor immune escape (42). Although we did not correlate the increased 572 
tumoral CD73 expression with tumor genotype, Nakagawa and colleagues reported 573 
CD73 expression on tumor cells in EGFR-mutation positive NSCLC increased after 574 
targeted treatment in patients with previously high PD-L1 expression (21). In triple 575 
negative breast cancer, chemotherapy enriches for a subset of tumor cells co-576 
expressing CD73/CD47/PD-L1 with immune evasive properties regulated, in part, via 577 
HIF1α (41). A limitation in our study is that we did not correlate increased membrane 578 
expression with enzymatic activity and extracellular adenosine production. In NSCLC, 579 
immune checkpoint inhibitors targeting PD-L1/PD-1 axis have shown clinically 580 
meaningful response rates in approximately 20% of patients; however, the majority of 581 
patients still derive no therapeutic benefit from immune checkpoint blockade (11). 582 
Recently, dual targeting of CD47 and PD-L1 on tumor cells in immunocompetent 583 
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preclinical mouse models showed enhanced therapeutic efficacy in controlling tumor 584 
growth, in part, via re-invigoration of the host immune system (27, 31). Therefore, 585 
targeting CD73 in combination with immune checkpoint blockers targeting PD-L1 and 586 
CD47 might represent a novel treatment strategy in a subset of patients with LUAD (20, 587 
36) that requires further investigation. 588 
  589 
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Figure 1. EpCAM+ cells enriched for CD73 found in both respiratory epithelium 796 
and alveolar region of postnatal lung. (A) Illustration of approach to identify and 797 
characterize epithelial cell subsets in human lung. (B-C) Representative flow plots are 798 
shown. (D) Scatter plots show percentage of cell subsets within EpCAM+ fraction (gate 799 
R4) after subgating for CD73 and CD90 in postnatal lung. (E) Scatter plots comparing 800 
EpCAM+CD73+ cell subset in postnatal versus adult human lung. N = 19, biological 801 
replicates for postnatal lung; N = 15, biological replicates for adult lung. (F, H) 802 
Hematoxylin and Eosin (H&E) stained unaffected postnatal lung. (G, I) Immunostaining 803 
of postnatal lung showing EpCAM (red) cells co-expressing CD73 (green, white arrow) 804 
in respiratory epithelium (G) and alveolar region (I). In the alveolus, CD73 cells lacking 805 
EpCAM are also found (white arrowhead). Nuclei were counterstained with DAPI. Br, 806 
bronchiole; Alv, alveolar; Lu, bronchiolar lumen. Scale bars 30 μm (G) and 20 μm (I). 807 
Data are presented as mean ± SD. Error bars show SD. P values are shown in the 808 
figure. 809 
 810 
Figure 2. EpCAM+CD73+ cells are basal cell-like after expansion in culture. (A) 811 
Diagram of assay to expand prospectively isolated EpCAM+CD73+ cells. Phase contrast 812 
image of cells after reaching confluence. (B) mRNA levels of genes marking proximal 813 
and distal airway cells and markers of basal stem cells, alveolar type II and type I cells in 814 
FACS-sorted EpCAM+CD73+ cells by RT-qPCR. Upper airway (n = 3, biological 815 
replicates), postnatal lung tissue (n = 5, biological replicates) and EpCAM+CD73+ cells 816 
(n = 9, biological replicates). Gene expression level in postnatal lung tissue is set at one. 817 
Representative immunofluorescence stains of FACS-sorted EpCAM+CD73+ cells (C, D) 818 
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and their quantification (E) after reaching confluence in culture (n = 3, biological 819 
replicates). Scale bar 50 μm (C, D). (F) Representative FACS plots demonstrating that 820 
HTII-280 marks a minor subset of EpCAM+CD73+ progenitor cells (gate R6). (G) Scatter 821 
plots showing co-expression of CD24 and PDPN. (postnatal, n = 6, biological replicates; 822 
adult, n = 7, biological replicates). (H) Schematic depicting the different cell subsets 823 
found within the EpCAM+CD73+ fraction after expansion in culture. Data are presented 824 
as mean ± SD. Error bars show SD. *P < 0.05; ns, not significant; ND, not detected. 825 
 826 
Figure 3. Disrupting epithelial NOTCH signaling alters mucociliary-secretory cell 827 
fate of EpCAM+CD73+ cells. (A) Representative hematoxylin and eosin (H&E) stain of 828 
unaffected lung showing normal bronchiole (Br) and surrounding alveolar region (Alv). 829 
(B) Immunostaining postnatal lung for TRP63 (red) and KRT5 (green). Higher-power 830 
view of boxed area shows dual positive TRP63-KRT5 cells (white arrow) and single 831 
positive TRP63 cells (white arrowhead) along the basal membrane. Nuclei were 832 
counterstained with DAPI. (C) Immunostaining postnatal lung for EpCAM (red), SOX2 833 
(white) and KRT5 (green). Higher power view of boxed area shows single layer of KRT5 834 
cells lining basal membrane. Nuclei were counterstained with DAPI. Br, bronchi; Alv, 835 
alveolar region. Scale bars 500 μm (A), 100 μm (B-C). Diagram of 2D air-liquid-interface 836 
(ALI) using either postnatal (D) or adult (F) EpCAM+CD73+ cells to examine the role of 837 
the NOTCH signaling pathway in airway differentiation. (D, F) Representative Z-stacks 838 
(upper panel: xy-projection; lower panel zy-projection) through different planes of ALI 839 
membranes showing formation of a pseudostratified mucociliary epithelium and impact 840 
of DLL4 (10 ng/ml) or DAPT (10 µM) on proximal airway differentiation. Ciliated (β-841 
tubulin, yellow) and goblet cells (MUC5AC, white) can be found at the apical surface 842 
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(apical xy plane). Images through the middle xy plane showing club cells (SCGB1A1, 843 
purple) together with E-cadherin (Ecad, green) showing changes in cell shape (white 844 
arrow). At the basal xy plane, representative images showing basal cells (TRP63, red). 845 
(E, G) 3D volume reconstruction of 2D differentiation at ALI to enable visualization basal 846 
cells (TRP63, red). n = 3, biological replicates. Scale bars: 500 µm (A), 100 µm (B, C), 847 
30 µm (D, F). 848 
 849 
Figure 4. EpCAM+CD73+ cells generate lung organoids recapitulating a 850 
mucociliary-secretory cell fate found in vivo. (A) Diagram of 3D airway organoid 851 
assay using EpCAM+CD73+ cells. (B) Transmission electron microscopy shows 852 
ultrastructural analysis of an individual organoid generated from postnatal (top) or adult 853 
(bottom) EpCAM+CD73+ cells. n=2, biological replicates. CC, ciliated cell; CR, ciliary 854 
rootlet; CZ, contact zone; NSC, nucleus of secretory cell; SC, secretory cell; SG, 855 
secretory granules. (C) mRNA levels of genes expressed by airway organoids using RT-856 
qPCR. n=4, biological replicates. Gene expression level in postnatal lung tissue is set at 857 
one. (D) Diagram of 3D alveolar organoid assay using EpCAM+CD73+ cells. Phase 858 
contrast image (4X) showing generation of organoid structures (right panel). (E) 859 
Representative immunofluorescence image of single alveolar organoids. Z stack 860 
showing saccule-like features, multicellular organization and lumen formation is 861 
highlighted. E-cadherin (red) is used to identify epithelial saccule-like structures and ATII 862 
cells stained for proSPC (green, white arrow) are shown. (F) Z-stack of an individual 863 
organoid showing KRT5+ cells and the location of ATI cells using the marker HOPX. 864 
Magnified Z-axis shows the location of HOPX+ cells facing in towards the lumen of the 865 
organoid. Nuclei were counterstained with DAPI (blue). Scale bars: 50 µm (E, F). Two of 866 
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three independent experiments are shown. (G) Representative FACS plot of alveolar 867 
organoids showing expression of CD73 and HTII-280 gated from EpCAM+ cells (left 868 
panel) and isotype for HTII-280 (right panel). (H) Scatter plots show percent of cell 869 
subsets within EpCAM+ fraction after subgating for CD73 and HTII-280. (I-J) Scatter 870 
plots showing percent of cell subsets within CD73+HTII-280- (I) or CD73+HTII-280+ 871 
fraction (J) after subgating for CD24 and PDPN. Data are presented as mean ± SD. *P < 872 
0.05; **P < 0.01. 873 
 874 
Figure 5. Cystic lung lesions lined with EpCAM+CD73+ cells. (A-D) Histological 875 
analysis of unaffected postnatal lung tissue (A) and congenital lung lesions (B-D). 876 
Bottom panels show boxed area at higher power. (E,G,I) Histological analysis (F,H,J) 877 
and immunostaining of CPAM (F), Chronic bronchiolitis (H) and CPAM (J) with EpCAM 878 
(green) and CD73 (red). Right panels show higher-power view of boxed area and single 879 
channels separated without DAPI to highlight co-stained cells. Nuclei are counterstained 880 
with DAPI (blue). Br, bronchiole; Alv, alveolar region; Lu, bronchiolar lumen. Scale bars: 881 
500 µm (G), 200 µm (A-D, E, I); 100 µm (F,H,J).  882 
 883 
Figure 6. Expansion in EpCAM+SCGB1A1+ and EpCAM+proSPC+ cells in distal 884 
lung compartment in congenital lesions and other airway abnormalities. 885 
Immunostaining shows cystic structures stained with EpCAM (red), SCGB1A1 (white) 886 
and proSPC (green) in CPAM (A, C) and lobar emphysema (E). (B,D,F) Right panels of 887 
higher-power view of boxed area highlight regions of dual positive EpCAM-SCGB1A1 888 
(yellow arrowhead) or EpCAM-proSPC (yellow arrow) stained cells. Channels are 889 
separated to show single stained cells. Br, bronchiole; Alv, alveolar region; Lu, 890 
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bronchiolar lumen. Scale bars: 100 µm (A,B,C,E,F); 50 µm (D),. Nuclei are 891 
counterstained with DAPI (blue). (G) Increase in EpCAM+proSPC+ and 892 
EpCAM+SCGB1A1+ cells per total number of EpCAM+ cells in disease compared with 893 
healthy area of lung. Data presented as mean ± SD, n = 3, biological replicates. 894 
 895 
Figure 7. Re-emergence of EpCAM+CD73+ cells in NSCLC coincides with 896 
increased expression of immune checkpoints and poor prognosis. (A,C) 897 
Hematoxylin and Eosin (H&E) staining of tumor specimen. (B) Higher-power view of 898 
boxed area from (A) shows dual positive EpCAM (green) and CD73 (Red) staining tumor 899 
islands (Tu) (B). (D) Serial section showing the nuclei of dual positive EpCAM-CD73 900 
tumor cells stain for TRP63 (red). Channels are separated to show single stained cells. 901 
(E-F) Scatter plots show frequency of EpCAM+ tumor cells enriched for CD73 in (E) 902 
LUAD (n = 64) and (F) LUSC (n = 58). (G-H) Scatter plots showing the mean 903 
fluorescence intensity (MFI) for PD-L1 and CD47 on EpCAM+CD73+ cell subset in (F) 904 
LUAD (n = 56 - 64) and (H) LUSC (n = 49 - 57). All data determined by flow cytometry.  905 
*P < 0.05; ***P < 0.0001; ns, not significant. (I) Representative images of PD-L1 and 906 
CD47 expression in serial sections from a single LUAD or LUSC patient. Scale bars: 500 907 
µm (C), 200 µm (A, B,), 100 µm (D), 50 µm (I). 908 
 909 
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